Photocat A/S
Change to Financial Calendar: New Publication Date for Annual Report.
Change to Financial Calendar: New Publication Date for Annual Report.
April 21st, 2025
Change to Financial Calendar: New Publication Date for Annual Report.
Roskilde, 21st April – Photocat A/S announces a revision to its financial calendar regarding the publication of the Annual Report for the financial year 2024.
Previously, the financial calendar indicated a publication date of 23 April 2025. This date was published in error and had not been confirmed with the company’s auditors. The Annual Report will instead be published on 6 May 2025, which is in accordance with the company’s Articles of Association and consistent with previous years’ reporting timelines.
We regret any inconvenience this may have caused and appreciate the understanding of our shareholders and stakeholders.
For more information, please contact:
Michael Humle
Photocat A/S
Tel: +45 7022 5055
Email: ka@photocat.net
About Photocat:
Photocat is a leader in sustainable solutions, harnessing the power of photocatalysis to create a cleaner, healthier world. Committed to environmental innovation, Photocat develops cutting-edge technologies that improve air quality. Photocat’s shares are listed on Nasdaq Stockholm, First North, under the ticker symbol PCAT. The company’s Certified Advisor is Eminova Fondkommission AB.
Photocat A/S (publ) l Langebjerg 4 DK-4000 Roskilde l Tel: +45 7022 5055 l www.photocat.net
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S18.10.2025 12:00:34 CEST | Press release
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
F. Hoffmann-La Roche Ltd18.10.2025 07:00:00 CEST | Press release
Roche’s phase III evERA data showed giredestrant significantly improved progression-free survival in people with ER-positive advanced breast cancer
StoneX Group Inc.18.10.2025 01:12:36 CEST | Press release
StoneX Expands Wealth Management Offering for Latin American Clients
F. Hoffmann-La Roche Ltd17.10.2025 22:20:00 CEST | Press release
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Eavor Technologies Inc.17.10.2025 18:00:00 CEST | Press release
Mark Fitzgerald Appointed President and Chief Executive Officer of Eavor Technologies Inc.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom